Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies
暂无分享,去创建一个
Xavier Woot de Trixhe | J. Byrd | G. Nicolao | R. Advani | S. O'brien | I. Poggesi | A. Vermeulen | J. Sukbuntherng | E. Marostica | D. Loury | J. Jong | J. McGreivy | X. W. Trixhe | J. Mcgreivy